Name | BMS-986313 |
---|
Description | BMS-986313 is a potent, selective, orally active RORγt inverse agonist with EC50 of 3.6 nM in GAL-4 reporter assay in Jurkat cell line, and 50 nM in IL-17 human whole blood assay.BMS-986313 demonstrated robust efficacy in preclinical models of psoriasis (the IMQ-induced skin lesion model and the IL-23-induced acanthosis model). |
---|---|
References | 1. Yang MG, et al. J Med Chem. 2021 Mar 11;64(5):2714-2724. |
Molecular Formula | C26H25F8NO4S |
---|---|
Molecular Weight | 599.536 |